The intersection of strategic business planning, regulatory compliance, and artificial intelligence (AI) will in great part define the next decade of medical device innovation in the United States. As advances in machine learning, predictive analytics, and connected health technologies accelerate, medical device firms face a dual imperative: To harness AI-driven efficiency while maintaining rigorous adherence to the regulatory expectations of the Food and Drug Administration (FDA) and...

Industrial, trucking and financial markets are already showing signs of stress or outright recession. The pending shock to the nation's healthcare delivery system will only add to the woes. A quick Google search reveals economic storm clouds are gathering, "Recent tariffs are a contributing factor to the current difficulties in the industrial and trucking sectors, intensifying an existing freight recession and contributing to job losses and reduced demand. While other factors like...

In today’s fast moving medtech landscape, traditional business planning and regulatory compliance are no longer enough to secure profitable growth. The game-changer is the intelligent integration of these disciplines with artificial intelligence (AI), a shift that promises to compress development timelines, reduce costs, and sharpen portfolio focus. Strategic business planning has always set the course—identifying market needs, competitive positioning, and reimbursement pathways. Yet, static...